Status:
COMPLETED
Group Lifestyle Intervention for People With New Onset Type 2 Diabetes.
Lead Sponsor:
The Royal Bournemouth Hospital
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of the study is to assess whether weight loss achieved through a programme of intensive lifestyle management can result in enhanced production of Glucagon-Like Peptide-1 (GLP-1) together w...
Detailed Description
The early management of type 2 diabetes usually consists of education related to lifestyle changes especially as 80 to 90% of people with type 2 diabetes are obese. Obesity worsens the metabolic and p...
Eligibility Criteria
Inclusion
- New onset of Type 2 Diabetes.
- BMI\>25kg/m2
Exclusion
- Antiobesity, oral hypoglycaemic medications or any other prescription medications that may interfere with the study results
- Pregnancy
- Unable to converse competently in English as special arrangements would need to be made for such people and this would be impractical in a group setting
- Attending another weight management programme
- Patients who would be unable to attend all the programme sessions for medical or other reasons
- Any patients from groups listed in A24
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT00705952
Start Date
January 1 2008
End Date
November 1 2008
Last Update
November 30 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.